13
Views
25
CrossRef citations to date
0
Altmetric
Original Paper: Nose/Sinus

Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity in nasal polyposis

&
Pages 290-296 | Received 04 Sep 2003, Accepted 06 Nov 2003, Published online: 08 Jul 2009

References

  • Mygind N. Nasal polyposis. J Allergy Clin Immunol 1990; 86: 827–9.
  • Ramsdale DH, Burns MW. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 1985; 75: 573–8.
  • Miles-Lawrence R, Kaplan M, Chang K. Metacholine sensitivity in nasal polyposis and the effects of poly-pectomy. J Allergy Clin Immunol 1982; 69: 102.
  • Peat JK, Salome CM, Woolcock AJ. Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J 1992; 5: 921–9.
  • Falliers CJ. First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome. J Asthma 1987; 24: 297–300.
  • Samter M, Beers RF. Concerning the nature of intoler-ance to aspirin. J Allergy 1967; 40: 281–93.
  • Lamblin C, Brichet A, Perez T, Darras J, Tonnel AB, Wallaert B. Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 2000; 161: 406–13.
  • Larsen PL, Tos M. Origin and structure of nasal polyps. In: Mygind N, Lilholdt T, editors. Nasal polyposis, an inflammatory disease and its treatment. Copenhagen: Munksgaard; 1997. p. 17–30.
  • MacKay IS, Lund VJ. Imaging and staging. In: Mygind N, Lilholdt T, editors. Nasal polyposis, an inflammatory disease and its treatment. Copenhagen: Munksgaard; 1997. p. 137–44.
  • Eiser NM, Kerrebijn KF, Quanjer PH. Guidelines for standardization of bronchial challenges with (nonspeci-fic) bronchoconstricting agents. Bull Eur Physiopathol Respir 1983; 19: 495–501.
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6(Suppl 16): 5–40.
  • Bonfils P, Norès JM, Halimi P, Avan P. Corticosteroid treatment in nasal polyposis with a three years follow-up period. Laryngoscope 2003; 113: 683–7.
  • Larsen K, Tos M. Clinical course of patients with primary nasal polyps. Acta Otolaryngol (Stockh) 1994; 114: 556–9.
  • Mygind N. Advances in the medical treatment of nasal polyps. Allergy 1999; 54(Suppl 53): 12–6.
  • Slavin RG. Medical management of nasal polyps and sinusitis. J Allergy Clin Immunol 1991; 88: 141–6.
  • Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111: 913–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.